Candida Species by PCR
Ordering Recommendation

Detect and differentiate C. albicans, C. glabrata, C. parapsilosis complex (C. parapsilosis, C. orthopsilosis, C. metapsilosis), C. tropicalis, C. krusei, and C. dubliniensis.

Qualitative Polymerase Chain Reaction
2-3 days
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
Body fluid, tissue, Lavender (EDTA), Pink (K2EDTA), or pure isolate of Candida species on potato dextrose agar (PDA), sabouraud dextrose agar, sheep blood agar, chocolate agar, or inhibitory mold agar. 
Specimen Preparation
Body Fluid: Transfer 1 mL body fluid to a sterile container. (Min: 0.5 mL).
Whole Blood: Transfer 2 mL whole blood to a sterile container. (Min: 1 mL).
Tissue: Transfer to a sterile container and freeze immediately.
Isolate: Transport sealed container with pure isolate on solid media. Place each specimen in an individually sealed bag. 
Storage/Transport Temperature
Body Fluid or Tissue: Frozen.
Isolate or Whole Blood:
Unacceptable Conditions
Plasma, serum, mixed cultures or isolates other than suspected Candida species. Isolates with no visible colonies. Isolates plated on CHROMagar chromogenic culture media. 
Specimen source required. 
Body Fluid: Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: 2 weeks
Whole Blood: Ambient: 1 week; Refrigerated; 1 week; Frozen: 1 week
Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 2 weeks
Isolate: Ambient: 1 week; Refrigerated: 2 weeks; Frozen: Unacceptable 
Reference Interval
Interpretive Data
A negative result does not rule out the presence of PCR inhibitors in the patient specimen or test-specific nucleic acid in concentrations below the level of detection by the test.

Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

This test detects and differentiates C. albicans, C. glabrata, C. parapsilosis complex (C. parapsilosis, C. orthopsilosis, C. metapsilosis), C. tropicalis, C. krusei, and C. dubliniensis.
Hotline History
View Hotline History
Component Test Code*Component Chart NameLOINC
2013785Candida Species Source31208-2
2013786Candida albicans by PCR
2013788Candida glabrata by PCR
2013790Candida parapsilosis complex by PCR
2013792Candida tropicalis by PCR
2013794Candida krusei by PCR
2013796Candida dubliniensis by PCR
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.